Nathalie Godefroid

Dr. Nathalie Godefroid


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2019 in Toxins
Verified
Journal Article
Open access
PDF file
ESEvelien Snauwaert
Evelien Snauwaert
EHEls Holvoet
Els Holvoet
WBWim Van Biesen
Wim Van Biesen
ARANN RAES
ANN RAES
Griet GlorieuxGriet Glorieux
Griet Glorieux
RSRukshana Shroff
Rukshana Shroff
Protein-bound uremic toxins (PBUTs) play a role in the multisystem disease that children on hemodialysis (HD) are facing, but little is known about their levels and protein binding (%PB). In this study, we evaluated the levels and %PB of six PBUTs cross-sectionally in a large pediatric HD cohort (n = 170) by comparing these with healthy and non-dialysis chronic kidney disease (CKD) stage 4–5 (n = 24) children. In parallel β2-microglobulin (β2M) and uric acid (UA) were evaluated. We then explored the impact of age and residual kidney function on uremic toxin levels and %PB using analysis of covariance and Spearman correlation coefficients (rs). We found higher levels of β2M, p-cresyl glucuronide (pCG), hippuric acid (HA), indole acetic acid (IAA), and indoxyl sulfate (IxS) in the HD compared to the CKD4–5 group. In the HD group, a positive correlation between age and pCG, HA, IxS, and pCS levels was shown. Residual urine volume was negatively correlated with levels of β2M, pCG, HA, IAA, IxS, and CMPF (rs −0.2 to −0.5). In addition, we found overall lower %PB of PBUTs in HD versus the CKD4–5 group, and showed an age-dependent increase in %PB of IAA, IxS, and pCS. Furhtermore, residual kidney function was overall positively correlated with %PB of PBUTs. In conclusion, residual kidney function and age contribute to PBUT levels and %PB in the pediatric HD population.

19 March 2021 in Toxins
Verified
Journal Article
Open access
PDF file
AAAmina El Amouri
Amina El Amouri
ESEvelien Snauwaert
Evelien Snauwaert
AFAurélie Foulon
Aurélie Foulon
CMCharlotte Vande Moortel
Charlotte Vande Moortel
MDMaria Van Dyck
Maria Van Dyck
SESunny Eloot
Sunny Eloot
Imbalanced colonic microbial metabolism plays a pivotal role in generating protein-bound uraemic toxins (PBUTs), which accumulate with deteriorating kidney function and contribute to the uraemic burden of children with chronic kidney disease (CKD). Dietary choices impact the gut microbiome and metabolism. The aim of this study was to investigate the relation between dietary fibre and gut-derived PBUTs in paediatric CKD. Sixty-one (44 male) CKD children (9 ± 5 years) were prospectively followed for two years. Dietary fibre intake was evaluated by either 24-h recalls (73%) or 3-day food records (27%) at the same time of blood sampling for assessment of total and free serum levels of different PBUTs using liquid chromatography. We used linear mixed models to assess associations between fibre intake and PBUT levels. We found an inverse association between increase in fibre consumption (g/day) and serum concentrations of free indoxyl sulfate (−3.1% (−5.9%; −0.3%) (p = 0.035)), free p-cresyl sulfate (−2.5% (−4.7%; −0.3%) (p = 0.034)), total indole acetic acid (IAA) (−1.6% (−3.0%; −0.3%) (p = 0.020)), free IAA (−6.6% (−9.3%; −3.7%) (p < 0.001)), total serum p-cresyl glucuronide (pCG) (−3.0% (−5.6%; −0.5%) (p = 0.021)) and free pCG levels (−3.3% (−5.8%; −0.8%) (p = 0.010)). The observed associations between dietary fibre intake and the investigated PBUTs highlight potential benefits of fibre intake for the paediatric CKD population. The present observational findings should inform and guide adaptations of dietary prescriptions in children with CKD.

4 October 2011 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
WTWilma F. Tromp
Wilma F. Tromp
NSNikki J. Schoenmaker
Nikki J. Schoenmaker
JLJohanna H. van der Lee
Johanna H. van der Lee
BABrigitte Adams
Brigitte Adams
ABAntonia H. M. Bouts
Antonia H. M. Bouts
JGJaap W. Groothoff
Jaap W. Groothoff
The low prevalence of childhood end-stage renal disease and the small centre sizes have been a barrier for clinical studies and the development of evidence-based guidelines for chronic renal replacement therapy (cRRT) in children. Few data exist on the quality of care for these patients and the applicability of existing guidelines. The aim of this study is to quantify variation in treatment policies and actually delivered care in nine centres that deliver cRRT for children. We surveyed treatment policies in all nine centres in the Netherlands and Belgium and compared them with the actually provided therapies and with recommendations from available guidelines. Data on treatment policies were gathered by questionnaires; actually provided care and outcomes were registered prospectively from 2007 to 2010. Data on policies and actual patient care were obtained from all nine centres. We found relevant differences between centres in treatment policies on various topics, e.g. estimated glomerular filtration rate threshold as an indication for initiation of cRRT, preferred initial mode of cRRT, peritoneal dialysis catheter care, haemodialysis frequency and vascular access. Discrepancies were seen between stated treatment policies and actual performed therapies. For the majority of policies, no evidence-based guidelines are available. Health care disparities exist due to large and unwanted variation in treatment policies between hospitals providing cRRT for children. Delivered care does not live up to stated policies, for which clear and internationally accepted guidelines are lacking.

2 January 2021 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
AAAmina El Amouri
Amina El Amouri
ESEvelien Snauwaert
Evelien Snauwaert
AFAurélie Foulon
Aurélie Foulon
CMCharlotte Vande Moortel
Charlotte Vande Moortel
MDMaria Van Dyck
Maria Van Dyck
SESunny Eloot
Sunny Eloot

6 August 2018 in Archives of Public Health
Verified
Journal Article
Open access
PDF file
SJS. Jacquinet
S. Jacquinet
KRKlara De Rauw
Klara De Rauw
DPDenis Pierard
Denis Pierard
NGNathalie Godefroid
Nathalie Godefroid
LCL. Collard
L. Collard
MSM. Sabbe
M. Sabbe
The Haemolytic Uremic Syndrome (HUS) is the most severe manifestation of infection with Shiga toxin-producing Escherichia coli (STEC). In Belgium, the surveillance of paediatric HUS cases is conducted by a sentinel surveillance network of paediatricians called Pedisurv. In this article, we present the main findings of this surveillance from 2009 to 2015 and we describe an annual incidence of HUS. For each case of HUS < 15 years notified by the paediatricians, clinical, microbiological and epidemiological data were collected by a questionnaire. National hospital discharge data with ICD-9 code 283.11 were used to calculate the incidence of HUS in children < 15 years. From 2009 to 2015, 110 cases were notified to the Pedisurv network with a mean annual notification rate of 0.8/100,000 in children < 15 years. Death occurred in 2.5% of all patients and the median number of days of hospitalization was 10 days. One third (35.4%) of the HUS cases were confirmed positive STEC, with a majority of STEC O157. The mean annual incidence based on the hospital discharge data was 3.2/100,000 in children < 15 years and 4.5/100,000 in children < 5 years. The incidence of paediatric HUS in Belgium is high compared to other European countries. Its surveillance in Belgium is quite comprehensive and, although less effective than monitoring all STEC infections to detect the emergence of outbreaks, is important to better monitor circulation of the most pathogenic STEC strains. In this context, efforts are still needed to send samples and STEC strains from HUS cases to the National Reference Centre.

16 March 2023 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
EBElke De Bruyne
Elke De Bruyne
LWLore Willem
Lore Willem
KHKoen Van Hoeck
Koen Van Hoeck
SRSarah Reynaert
Sarah Reynaert
SVSylvie Vankerckhove
Sylvie Vankerckhove
ELElena Levtchenko
Elena Levtchenko